Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Patard

Showing results (111-120 of 154) with videos related to

Pageof 16
Sort By:
The Journal of Urology|November 7, 2001
T helper 1/2 lymphocyte urinary cytokine profiles in responding and nonresponding patients after 1 and 2 courses of bacillus Calmette-Guerin for superficial bladder cancerF Saint, J J Patard, P Maille, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 14, 2015
[Not Available]A Brunot, J Dagher, C Perrin, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 5, 1998
[Improvement over time of oncological results after radical prostatectomy: what are the responsible factors?]L Salomon, A Herard, M Colombel, et al.
International Journal of Cancer|February 20, 1995
Expression of MAGE genes in transitional-cell carcinomas of the urinary bladderJ J Patard, F Brasseur, S Gil-Diez, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 13, 2009
[Atypical cysts and cystic tumours of the kidney: histological, radiological and surgical considerations. Conclusions of the AFU 2007 forum]J-A Long, Y Neuzillet, J-M Correas, et al.
British Journal of Cancer|March 6, 2014
Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinomaA Saroufim, Y Messai, M Hasmim, et al.
Clinical and Experimental Immunology|November 15, 2006
Interleukin-6 and vascular endothelial growth factor release by renal cell carcinoma cells impedes lymphocyte-dendritic cell cross-talkF Cabillic, F Bouet-Toussaint, O Toutirais, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 13, 2001
[Natural history of vascular ports for hemodialysis after renal transplantation]K Bensalah, F Guillé, J Rivalan, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2010
[Treatment of metastatic kidney cancer in elderly subjects]B Escudier, P Paparel, Y Neuzillet, et al.
Human Pathology|December 1, 2001
Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinomaN Rioux-Leclercq, J I Epstein, J Y Bansard, et al.
Pageof 16

Showing results (111-120 of 154) with videos related to

Sort By:
Pageof 16
The Journal of Urology|November 7, 2001
T helper 1/2 lymphocyte urinary cytokine profiles in responding and nonresponding patients after 1 and 2 courses of bacillus Calmette-Guerin for superficial bladder cancerF Saint, J J Patard, P Maille, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 14, 2015
[Not Available]A Brunot, J Dagher, C Perrin, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 5, 1998
[Improvement over time of oncological results after radical prostatectomy: what are the responsible factors?]L Salomon, A Herard, M Colombel, et al.
International Journal of Cancer|February 20, 1995
Expression of MAGE genes in transitional-cell carcinomas of the urinary bladderJ J Patard, F Brasseur, S Gil-Diez, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 13, 2009
[Atypical cysts and cystic tumours of the kidney: histological, radiological and surgical considerations. Conclusions of the AFU 2007 forum]J-A Long, Y Neuzillet, J-M Correas, et al.
British Journal of Cancer|March 6, 2014
Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinomaA Saroufim, Y Messai, M Hasmim, et al.
Clinical and Experimental Immunology|November 15, 2006
Interleukin-6 and vascular endothelial growth factor release by renal cell carcinoma cells impedes lymphocyte-dendritic cell cross-talkF Cabillic, F Bouet-Toussaint, O Toutirais, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 13, 2001
[Natural history of vascular ports for hemodialysis after renal transplantation]K Bensalah, F Guillé, J Rivalan, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2010
[Treatment of metastatic kidney cancer in elderly subjects]B Escudier, P Paparel, Y Neuzillet, et al.
Human Pathology|December 1, 2001
Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinomaN Rioux-Leclercq, J I Epstein, J Y Bansard, et al.
Pageof 16